Myocytes die by multiple mechanisms in failing human hearts

Circulation Research

Volumn 92, Issue 7, 2003, Pages 715-724

  Kostin, Sawa ^a   Pool, Lieven ^a   Elsässer, Albrecht ^c   Hein, Stefan ^b   Drexler, Hannes C A ^a   Arnon, Eyal ^a   Hayakawa, Yukihiro ^a   Zimmermann, René ^b   Bauer, Erwin ^b   Klövekorn, Wolf Peter ^b   Schaper, Jutta ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Apoptosis; Autophagy; Cell death; Oncosis; Ubiquitin

Indexed keywords

CASPASE 3; CATHEPSIN D; ENZYME; ISOPEPTIDASE; LIGASE; MESSENGER RNA; PROTEASOME; PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL LOSS; CELL NUCLEUS; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DEGRADATION; DOWN REGULATION; ENZYME ACTIVATION; EXPLANT; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MUSCLE CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA ANALYSIS; STAINING; ULTRASTRUCTURE; UPREGULATION;

APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CARBON-NITROGEN LYASES; CARDIOMYOPATHY, DILATED; CATHEPSIN D; CYSTEINE ENDOPEPTIDASES; HUMANS; IN SITU NICK-END LABELING; LIGASES; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; MULTIENZYME COMPLEXES; MYOCYTES, CARDIAC; NECROSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 0037453585     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000067471.95890.5C     Document Type: Article

References (43)

1. Olivetti G, Giordano G, Corradi G, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects in the human heart. J Am Coll Cardiol. 1995;26:1068-1079.
2. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klövekorn W-P, Schlepper M, Schaper W, Schaper J. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res. 2000;86:846-853.
3. Anversa PL, Kajstura J, Guerra S, Beltrami CA. Myocyte death and growth in the failing heart. Lab Invest. 1998;78:767-786.
4. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
5. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
6. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski CA, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
7. Ohno M, Takemura G, Ohno H, Misao J, Hayakawa Y, Minatoguchi S, Fujiwara T, Fujiwara H. "Apoptotic" myocytes in the infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end labeling. Circulation. 1998;98:1422-1430.
8. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Minatoguchi S, Fujiwara H. Significance of myocytes with positive DNA end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation. 1999;99:2757-2764.
9. Schaper J, Elsässer A, Kostin S. The role of cell death in heart failure. Circ Res. 1999;85:867-869.
10. Schaper J, Lorenz-Meyer S, Suzuki K. The role of apoptosis in dilated cardiomyopathy. Herz. 1999;24:219-224.
11. Majno G, Joris I. Apoptosis, oncosis and necrosis. Am J Pathol. 1995;146:3-15.
12. Doran JP, Howie AJ, Townend JN. Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. J Clin Pathol. 1996;49:34-37.
13. Ferreira MAS, Owen HE, Howie AJ. High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology. J Clin Pathol. 1998;51:548-551.
14. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Diff. 1999;6:508-515.
15. Lockshin RA, Osborne B, Zakeri Z. Cell death in the third millennium. Cell Death Diff. 2000;7:2-7.
16. Blommaart EFC, Luiken JJFP, Meijer AJ. Autophagic proteolysis: control and specificity. Histochem J. 1997;29:365-385.
17. Hass AL, Baboshina O, Williams B, Schwartz LM. Coordinated induction of the ubiquitin conjugating pathway accompanies the developmentally programmed death of insect skeletal muscle. J Biol Chem. 1995;270:9407-9412.
18. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigen A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 1997;12:25-31.
19. Stadelman C, Deckwerth TL, Srinivasan A, Bancher C, Brück W, Jellinger K, Lassmann H. Activation of caspase-3 in single apoptotic neurons and granules of granulovacuolar degeneration in Alzheimer's disease and Down syndrome: a role for autophagy as antiapoptotic counterregulatory mechanism. Am J Pathol. 1999;155:1459-1466.
20. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717-1720.
21. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82:373-428.
22. Eble DM, Spragia ML, Ferguson AG, Samarel AM. Sarcomeric myosin heavy chain is degraded by the proteasome. Cell Tissue Res. 1999;296:541-548.
23. Bursch W, Hochegger K, Török L, Marian B, Ellinger A, Hermann RS. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci. 2000;113:1189-1198.
24. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res. 2001;51:304-312.
25. Nishino I, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;24:906-10.
26. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83:504-514.
27. Biederbick A, Kern HF, Elsässer HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995;66:3-14.
28. Narula J, Arbustini E, Chandrashekhar Y, Schwaiger M. Apoptosis and the systolic dysfunction in congestive heart failure: story of apoptosis interruptus and zombie myocytes. Cardiol Clin. 2001;19:113-126.
29. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A. 2002;99:6252-6256.
30. Devaux B, Scholz D, Hirche A, Klövekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J. 1997;18:470-479.
31. Afanasyeva M, Rose NR. Cardiomyopathy is linked to complement activation. Am J Pathol. 2002;161:351-357.
32. Jennings RB, Steenbergen C, Kinney RB, Hill ML, Reimer KA. Comparison of the effect of ischemia and anoxia on the sarcolemma of the dog heart. Eur Heart J. 1983;4:123-137.
33. Turner GC, Varshavsky A. Detecting and measuring cotranslational protein degradation in vivo. Science. 2000;289:2117-2120.
34. Ciechanover A, Orian A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem. 2000;34:40-51.
35. Hadari T, Warms JV, Rose IA, Hershko A. A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains: role in protein degradation. J Biol Chem. 1992:267:719-727.
36. Lam YA, Pickart CM. Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A. 2000;97:9902-9906.
37. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998;21:516-520.
38. Weissman AM. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2001;2:169-178.
39. Johnson ES, Ma PC, Ota IM, Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem. 1995;270:17442-17456.
40. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitinproteasome system by protein aggregation. Science. 2001;292:1552-1555.
41. Liu Z, Miers WR, Wei L, Barrett EJ. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes. Biophys Biochem Res Comm. 2000;276:1255-1260.
42. Jellinger KA. Cell death mechanisms in Parkinson's disease. J Neural Transm. 2000;107:1-29.
43. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci. 2001;15:9549-9560.